ALTICE USA ($ATUS) is expected to release its quarterly earnings data on Thursday, May 8th before market open, per Finnhub. Analysts are expecting revenue of $2,200,944,780 and earnings of -$0.06 per share.
You can see Quiver Quantitative's $ATUS stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
ALTICE USA Insider Trading Activity
ALTICE USA insiders have traded $ATUS stock on the open market 105 times in the past 6 months. Of those trades, 0 have been purchases and 105 have been sales.
Here’s a breakdown of recent trading of $ATUS stock by insiders over the last 6 months:
- ALT S.A.R.L. NEXT has made 0 purchases and 105 sales selling 28,182,984 shares for an estimated $690,483,108.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
ALTICE USA Hedge Fund Activity
We have seen 67 institutional investors add shares of ALTICE USA stock to their portfolio, and 70 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC removed 20,875,473 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $50,309,889
- EMPYREAN CAPITAL PARTNERS, LP added 15,700,000 shares (+785.0%) to their portfolio in Q4 2024, for an estimated $37,837,000
- JPMORGAN CHASE & CO added 4,541,359 shares (+238.7%) to their portfolio in Q4 2024, for an estimated $10,944,675
- BOUNDARY CREEK ADVISORS LP removed 3,623,219 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $8,731,957
- UBS GROUP AG added 2,809,058 shares (+94.5%) to their portfolio in Q4 2024, for an estimated $6,769,829
- BRACEBRIDGE CAPITAL, LLC added 2,322,337 shares (+35.5%) to their portfolio in Q4 2024, for an estimated $5,596,832
- BALYASNY ASSET MANAGEMENT L.P. removed 2,316,169 shares (-86.0%) from their portfolio in Q4 2024, for an estimated $5,581,967
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
